Understanding cancer evolution is crucial for developing effective therapies. Here, authors present TreeMHN, a probabilistic model for inferring exclusivity patterns of genomic events and evolutionary trajectories from intra-tumor phylogenetic trees.
- Xiang Ge Luo
- Jack Kuipers
- Niko Beerenwinkel
